Gaurav Chatterjee (@gaurav_c42) 's Twitter Profile
Gaurav Chatterjee

@gaurav_c42

Hematopathologist @ACTREC_TMC @TataMemorial. @India_Alliance Intermediate fellow. Genomics. ctDNA. Instrumental. Love Riva, Kajari and Freedom.

ID: 1187949993673379841

calendar_today26-10-2019 04:32:14

913 Tweet

781 Followers

544 Following

Ashwin Kishtagari, MD (@ashkishtagari) 's Twitter Profile Photo

I am thrilled to share our new publication in @eClinicalMedicine co-led with a superb Vanderbilt Health IM resident James Brogan: "Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis" sciencedirect.com/science/articl… We analyzed 805,249 participants

Charlotte Brierley (@ckbrierley) 's Twitter Profile Photo

🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in Nature Genetics 🧬! shorturl.at/94s5S We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n 🧵👇

🚨🚨Paper out! 🚨🚨
Delighted to share our work, now published in <a href="/NatureGenet/">Nature Genetics</a> 🧬! shorturl.at/94s5S

We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n

🧵👇
Nikhil Patkar (@nvpatkar) 's Twitter Profile Photo

🚨 We're Hiring: Research Scientist II 📍 Location: ACTREC–TMC, 🇮🇳 💰 Pay: ₹87,100/month 📅 Apply by: 16th July 2025 📧 Send your CV + supporting documents to: [email protected] Ad Details: tinyurl.com/4hr5z5hx

🚨 We're Hiring: Research Scientist II

📍 Location: ACTREC–TMC, 🇮🇳

💰 Pay: ₹87,100/month

📅 Apply by: 16th July 2025

📧 Send your CV + supporting documents to: molhematevent@gmail.com

Ad Details:
tinyurl.com/4hr5z5hx
PIB in Maharashtra 🇮🇳 (@pibmumbai) 's Twitter Profile Photo

Landmark achievement in cancer care!🛡️ India’s first high-dose 131-I MIBG therapy for neuroblastoma was successfully performed at ACTREC, Tata Memorial Centre, Navi Mumbai, on May 5, 2025. 🧵 (1/5)

Landmark achievement in cancer care!🛡️

India’s first high-dose 131-I MIBG therapy for neuroblastoma was successfully performed at ACTREC, Tata Memorial Centre, Navi Mumbai, on May 5, 2025.
🧵
(1/5)
Ilaria Iacobucci (@ilariaiacobucc1) 's Twitter Profile Photo

📣 Cell developmental state matters in B-ALL. Our study out today in ⁦Nature Cancer⁩: Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features | Nature Cancer nature.com/articles/s4301…

Koichi Takahashi (@drktakahashi) 's Twitter Profile Photo

🚨 New paper in Nature Genetics ! How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-related myeloid neoplasms? We uncovered this process through single-colony WGS! See the full paper here! nature.com/articles/s4158…

ESMO Open (@esmo_open) 's Twitter Profile Photo

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay in ESMO Open. Mostly early stage RCC, promising non-invasive tool based on 3 cfDNA features integrated into a stacked ensemble ML model. esmoopen.com/article/S2059-…

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay in <a href="/ESMO_Open/">ESMO Open</a>. Mostly early stage RCC, promising non-invasive tool  based on 3 cfDNA features integrated into a stacked ensemble ML model. esmoopen.com/article/S2059-…
paresh vyas (@pvyas_oxford) 's Twitter Profile Photo

Detecting and quantifying clonal selection in somatic stem cells | Nature Genetics. So pleased to share this work. It is one of the most important pieces of work we have done. Huge thanks to all. More improvements on SCIFER to come! nature.com/articles/s4158…

Nikhil Patkar (@nvpatkar) 's Twitter Profile Photo

It is heartening to read that scientific inventions from academia can form startups. In the medical colleges in India, such ventures are largely unheard of (to the best of my knowledge) because pathways for doctors to do this simply don't exist. Shame

It is heartening to read that scientific inventions from academia can form startups. 

In the medical colleges in India, such ventures are largely unheard of (to the best of my knowledge) because pathways for doctors to do this simply don't exist. 

Shame
Khushali Jhaveri (@jhaverikhushali) 's Twitter Profile Photo

Just published in The ASCO Post My reflections from ICML 2025 — where lymphoma history met its future. From COO giving way to molecular clusters, to the TME guiding CART outcomes, to the undeniable momentum in aggressive B-cell lymphoma 👉 ascopost.com/news/july-2025… #ICML2025 #lymsm

Andreas Hochhaus (@andreashochhaus) 's Twitter Profile Photo

Just published: on behalf of the European LeukemiaNet, the international expert panel led by Prof Jane Apperley presented the 2025 management recommendations of chronic myeloid leukemia (CML) in LEUKEMIA Leukemia Journal open access. nature.com/articles/s4137…

Sumeet Mirgh MD, DM (@mirghsumeet) 's Twitter Profile Photo

Just published in CancerMedicine 15 years of PBSC mobilization experience in Myeloma Even in the CAR-T era, collecting sufficient PBSCs is crucial. - GCSF+plerixafor comparable to chemo mobilization - If prior RT (to hematopoietic sites - spine, pelvis), chemo-mobn is better

Just published in <a href="/CancerMedicine/">CancerMedicine</a>
15 years of PBSC mobilization experience in Myeloma

Even in the CAR-T era, collecting sufficient PBSCs is crucial.

- GCSF+plerixafor comparable to chemo mobilization
- If prior RT (to hematopoietic sites - spine, pelvis), chemo-mobn is better
Bernardo Rodriguez Martin (@bernirdgz) 's Twitter Profile Photo

*New Open-Access Long Read Resource*. We sequenced 1,019 genomes from the 1000 Genomes Project sample cohort using Oxford Nanopore. Sequencing data is available at bit.ly/4m8dlE2. EMBL Heinrich-Heine-Universität Düsseldorf IMP Centre for Genomic Regulation (CRG) nature.com/articles/s4158… [1/8]

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Just out! Current Risk stratification of all Plasma Cell Disorders. MGUS, SMM, Myeloma, Amyloidosis. We paid Open Access fees so you can download and read freely! Lots of Tables. Bookmark. Saurabh Zanwar Shaji Kumar Leukemia Journal Link: nature.com/articles/s4137…

Just out! Current Risk stratification of all Plasma Cell Disorders. MGUS, SMM, Myeloma, Amyloidosis. 

We paid Open Access fees so you can download and read freely! Lots of Tables. Bookmark. 
<a href="/ZanwarSaurabh/">Saurabh Zanwar</a> <a href="/myelomaMD/">Shaji Kumar</a> <a href="/LeukemiaJnl/">Leukemia Journal</a> 

Link: nature.com/articles/s4137…
ananthvikas (@ananthvikas) 's Twitter Profile Photo

The BMRD #flowcytometry workshop at ⁦ACTREC-TMC⁩ is off to a great start with amazing talks from ⁦Pgs_mani⁩ , ⁦Orfao Lab⁩ and ⁦Sweta Rajpal⁩ . Lot of insightful discussions and revelations, in a packed hall! ⁦THE CYTOMETRY SOCIETY⁩ ⁦

The BMRD #flowcytometry workshop at ⁦<a href="/ACTREC_TMC/">ACTREC-TMC</a>⁩ is off to a great start with amazing talks from ⁦<a href="/P_G_Subramanian/">Pgs_mani</a>⁩ , ⁦<a href="/LabOrfao/">Orfao Lab</a>⁩ and ⁦<a href="/RajpalSweta/">Sweta Rajpal</a>⁩ . Lot of insightful discussions and revelations, in a packed hall! ⁦<a href="/CytometryIndia/">THE CYTOMETRY SOCIETY</a>⁩ ⁦